Baseline and ontreatment predictors of svr to peginterferon alfa-2a therapy and ribavirin in hcv genotype (GT) 1 treatment naive patients: New insights from the chariot study

Weltman, M, Dore, GJ, Sievert, W, McCaughan, GW, Crawford, DH, Cheng, W, Rawlinson, W, Yashihara, M, McCloud, PI, Rizkalla, B and Roberts, SK (2009). Baseline and ontreatment predictors of svr to peginterferon alfa-2a therapy and ribavirin in hcv genotype (GT) 1 treatment naive patients: New insights from the chariot study. In: HEPATOLOGY. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston MA, (1033A-1034A). OCT 30-NOV 03, 2009.

Author Weltman, M
Dore, GJ
Sievert, W
McCaughan, GW
Crawford, DH
Cheng, W
Rawlinson, W
Yashihara, M
McCloud, PI
Rizkalla, B
Roberts, SK
Title of paper Baseline and ontreatment predictors of svr to peginterferon alfa-2a therapy and ribavirin in hcv genotype (GT) 1 treatment naive patients: New insights from the chariot study
Conference name 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Conference location Boston MA
Conference dates OCT 30-NOV 03, 2009
Proceedings title HEPATOLOGY   Check publisher's open access policy
Journal name Hepatology   Check publisher's open access policy
Publication Year 2009
Sub-type Published abstract
ISSN 0270-9139
Volume 50
Issue 4
Start page 1033A
End page 1034A
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Wed, 09 Mar 2011, 15:52:31 EST